Protagonist Therapeutics Inc (PTGX) Implied Volatility Current

Tracking PTGX implied volatility helps you identify when options premiums on Protagonist Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Protagonist Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when PTGX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Protagonist Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For PTGX, tracking metrics like PTGX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on PTGX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorders; PN-943, an oral, alpha-4-beta-7 integrin- specific antagonist peptide that is in Phase II clinical trials for treating inflammatory bowel disease (IBD); and PN-235, an orally delivered interleukin-23 receptor specific antagonist for the treatment of IBD and non-IBD indications.

The company has a license and collaboration agreement with Janssen Biotech, Inc. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where PTGX implied volatility sits today versus where it has been. Our scanner ranks Protagonist Therapeutics Inc implied volatility against its historical range, surfaces extremes in PTGX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Protagonist Therapeutics Inc IV is rich or cheap — measure it, then act on it.